Back to Search Start Over

Validation of Clinical Risk Models for Clostridioides difficile - Attributable Outcomes

Authors :
Gregory R. Madden
William A. Petri
Deiziane V. S. Costa
Cirle A. Warren
Jennie Z. Ma
Costi D. Sifri
Source :
Antimicrobial Agents and Chemotherapy. 66
Publication Year :
2022
Publisher :
American Society for Microbiology, 2022.

Abstract

Clostridioides difficile is the leading health care-associated pathogen, leading to substantial morbidity and mortality; however, there is no widely accepted model to predict C. difficile infection severity. Most currently available models perform poorly or were calibrated to predict outcomes that are not clinically relevant.

Details

ISSN :
10986596 and 00664804
Volume :
66
Database :
OpenAIRE
Journal :
Antimicrobial Agents and Chemotherapy
Accession number :
edsair.doi...........06ace523111ea15932886ca71e02fe8a